Andrej Sali received his BSc degree in chemistry from the University of Ljubljana,
Slovenia, in 1987; and his PhD from Birkbeck College, University of London, UK, in
1991, under the supervision of Professor Tom L. Blundell, where he developed the
MODELLER program for comparative modeling of protein structures. He was then a
postdoc with Professor Martin Karplus at Harvard University as a Jane Coffin Childs
Memorial Fund fellow, studying lattice Monte Carlo models of protein folding. From
1995 to 2002, he was first an Assistant Professor and then an Associate Professor at
The Rockefeller University. In 2003, he moved to University of California, San
Francisco, as a Professor of Computational Biology in the Department of
Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry,
and California Institute for Quantitative Biosciences (QB3). He was a Sinsheimer
Scholar (1996), an Alfred P. Sloan Research Fellow (1998), an Irma T. Hirschl Trust
Career Scientist (2000), and the recipient of the Zois Award of Science Ambassador
of Republic of Slovenia (2007). He is an Editor of Structure and a Founder of
Prospect Genomix that merged with Structural Genomix, finally acquired by E. Lilly &
Co. Dr. Sali is interested in developing and applying computational methods for
determining structures and functions of proteins and their assemblies.